
About
LxBio AB is a CRO in Lisboa, Portugal that supports therapeutic and research antibody discovery, optimization, production, characterization, and cell line development. It serves clients developing antibody programs with single B-cell technology, phage display, and antibody engineering workflows.
Services
Single B Cell Antibody Discovery
Screens and isolates individual antigen-specific B cells to identify high-specificity, high-affinity antibody candidates.
Assays & in vitro testing
Phage Display Antibody Discovery
Provides phage display-based discovery from immunization through top-clone selection, including library creation and multiple antibody formats.
Assays & in vitro testing
Antibody Optimization
Improves antibody affinity, specificity, stability, humanization, and effector function for therapeutic or diagnostic use.
Assays & in vitro testing
Affinity Maturation
Uses library construction and random mutagenesis to generate higher-affinity antibody candidates, with cloning, expression, purification, and quality assessment.
Assays & in vitro testing
Antibody Conversion
Humanizes murine or other species-derived antibodies and reformats antibodies without compromising binding or function.
Assays & in vitro testing
Effector Function Optimization
Engineers Fc regions to enhance antibody effector activity.
Assays & in vitro testing
Antibody Production
Provides gene-to-antibody and small-scale research-grade antibody production with purification and quality assessment.
Protein production
Single Cell Line Development
Develops stable antibody-producing cell lines using single-cell isolation, real-time productivity assessment, and clone selection.
Cell line development
Antibody Characterization
Performs early-stage and late-stage antibody characterization to assess affinity, specificity, developability, potency, safety, and regulatory readiness.
Assays & in vitro testing
Binding Affinity and Specificity Analysis
Uses SPR and epitope binning or mapping to measure binding kinetics and define selectivity.
Assays & in vitro testing
Developability Assessment
Screens antibodies in silico and in vitro for aggregation propensity, solubility, and chemical liabilities.
Assays & in vitro testing
Functional Characterization
Assesses antibody mechanism-related functions such as ADCC, CDC, PK, and stability.
Assays & in vitro testing
- Turnaround
- Sample to sequence in weeks · Cell line development timeline to just 3 weeks
- What to send
- Amino acid or nucleotide sequence · Antigen-specific B cells · Animal immunization for phage display
Capabilities
- Assays and studies
- Antibodies · Phage display · Rodent models · In vivo · CHO · Single B-cell screening · High-resolution functional assays · SPR · Epitope binning · Epitope mapping · SDS-PAGE · ELISA
8 more
SEC-HPLC · DSC · DLS · MS · ADCC assays · CDC assays · PK studies · Stability studies - Scale and capacity
- Yields ranging from a few milligrams to hundreds of milligrams · Cell line development timeline to just 3 weeks
- Therapeutic areas
- Therapeutic antibodies · Diagnostic antibodies · Research antibodies
Instruments and platforms
- Surface Plasmon Resonance (SPR)
Modalities and species
- Modalities
- Antibody
- Species and models
- Human · Rabbit · Rat · Chicken · Camelid · Sheep · Monkey · CHO cells
Company
- Type
- CRO
Locations
- Based in
- Lisbon, Portugal
- Sites
- Lisboa, Portugal
Similar labs
Work here? Claim this listing